Literature DB >> 29700963

Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract.

J Nee1, V Rangan1, A Lembo1.   

Abstract

The use of opioid medications for acute and chronic pain has increased significantly in the past 20 years in the United States. Given the high density of opioid receptors in the gastrointestinal tract, side effects are common in these patients including constipation, dysphagia, bloating, nausea, and vomiting. These side effects, which are experienced by most patients who take opioids, can lead to significant impairment in quality of life. Unlike other side effects from opioids, gastrointestinal side effects do not diminish with continued use, often leading patients to reduce or discontinue their opioid treatment to relieve these side effects. Therefore, physicians must be aware and anticipate potential side effects in patients receiving opioids to ensure appropriate pain management.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  constipation; dysmotility; opioids

Mesh:

Substances:

Year:  2018        PMID: 29700963     DOI: 10.1111/nmo.13367

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  4 in total

1.  Endoscopic ultrasound: a powerful tool to modify treatment algorithms in opioid-induced achalasia.

Authors:  Arielle M Lee; Josefin Holmgren; Ryan C Broderick; Joslin N Cheverie; Bryan J Sandler; Garth R Jacobsen; Wilson T Kwong; David C Kunkel; Santiago Horgan
Journal:  Surg Endosc       Date:  2020-08-26       Impact factor: 4.584

Review 2.  Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?

Authors:  Maura Corsetti; Jasper Pannemans; Peter Whorwell
Journal:  F1000Res       Date:  2019-03-05

3.  Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial.

Authors:  Cecilie Siggaard Knoph; Mathias Ellgaard Cook; Camilla Ann Fjelsted; Srdan Novovic; Michael Bau Mortensen; Liv Bjerre Juul Nielsen; Mark Berner Hansen; Jens Brøndum Frøkjær; Søren Schou Olesen; Asbjørn Mohr Drewes
Journal:  Trials       Date:  2021-12-19       Impact factor: 2.279

4.  Magnesium and Morphine in the Treatment of Chronic Neuropathic Pain-A Biomedical Mechanism of Action.

Authors:  Kamila Kulik; Barbara Żyżyńska-Granica; Agnieszka Kowalczyk; Przemysław Kurowski; Małgorzata Gajewska; Magdalena Bujalska-Zadrożny
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.